Advanced search
Publication Cover
Drug Delivery Volume 24, 2017 - Issue 1
Submit an article Journal homepage
1,590
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Reversed lipid-based nanoparticles dispersed in oil for malignant tumor treatment via intratumoral injection

Liao ShenBeijing Institute of Pharmacology and Toxicology, Beijing100850, ChinaView further author information
,
Zhen ZhangBeijing Institute of Pharmacology and Toxicology, Beijing100850, ChinaView further author information
,
Tao WangBeijing Institute of Pharmacology and Toxicology, Beijing100850, ChinaView further author information
,
Xi YangBeijing Institute of Pharmacology and Toxicology, Beijing100850, ChinaView further author information
,
Ri HuangBeijing Institute of Pharmacology and Toxicology, Beijing100850, ChinaView further author information
&
Dongqin QuanBeijing Institute of Pharmacology and Toxicology, Beijing100850, ChinaCorrespondence[email protected]
View further author information
Pages 857-866 | Received 16 Mar 2017, Accepted 10 May 2017, Published online: 26 May 2017

References

  • A'hern RP, Smith IE, Ebbs SR. (1993). Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimens. Br J Cancer 67:801–5.
  • Al-Abd AM, Hong KY, Song SC, Kuh HJ. (2010). Pharmacokinetics of doxorubicin after intratumoral injection using a thermosensitive hydrogel in tumor-bearing mice. J Control Release 142:101–7.
  • Bao AD, Phillips WT, Goins B, et al. (2006). Potential use of drug carried-liposomes for cancer therapy via direct intratumoral injection. Int J Pharm 316:162–9.
  • Cao Y, Zhang C, Shen W, et al. (2007). Poly(N-isopropylacrylamide)–chitosan as thermosensitive in situ gel-forming system for ocular drug delivery. J Control Release 120:186–94.
  • Carter SK, Soper WT. (1974). Integration of chemotherapy into combined modality treatment of solid tumors. 1. The Overall Strategy Cancer Treat Rev 1:1–13.
  • Chari RV. (2008). Targeted cancer therapy: conferring specificity to cytotoxic drugs. Acc Chem Res 41:98–107.
  • Chun C, Lee SM, Kim CW, et al. (2009). Doxorubicin-polyphosphazene conjugate hydrogels for locally controlled delivery of cancer therapeutics. Biomaterials 30:4752–62.
  • De Souza R, Zahedi P, Allen CJ, Piquette-Miller M. (2010). Polymeric drug delivery systems for localized cancer chemotherapy. Drug Deliv 17:365–75.
  • Ding Q, Li Z, Yang Y, et al. (2016). Preparation and therapeutic application of docetaxel-loaded poly(d,l-lactide) nanofibers in preventing breast cancer recurrence. Drug Deliv 23:2677–85.
  • Freitas S, Merkle HP, Gander B. (2005). Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Release 102:313–32.
  • Goins B, Phillips WT, Bao A. (2016). Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy. Expert Opin Drug Deliv 13:873–89.
  • Jenkins DE, Oei Y, Hornig YS. (2003). Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin Exp Metastasis 20:733–44.
  • Jeong B, Kim SW, Bae YH. (2002). Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev 54:37–51.
  • Lewis BJ. (1995). A Comparison of Lipiodol Chemoembolization and Conservative Treatment for Unresectable Hepatocellular Carcinoma. N Engl J Med 332:1256–61.
  • Llovet JM, Bruix J. (2003). Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429–42.
  • Moreno E, Schwartz J, Larraneta E, et al. (2014). Thermosensitive hydrogels of poly(methyl vinyl ether-co-maleic anhydride) - Pluronic (R) F127 copolymers for controlled protein release. Int J Pharm 459:1–9.
  • Nomura T, Koreeda N, Yamashita F, et al. (1998). Effect of particle size and charge on the disposition of lipid carriers after intratumoral injection into tissue-isolated tumors. Pharm Res 15:128–32.
  • Ruan G, Feng SS. (2003). Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials 24:5037–44.
  • Wang X, Wang J, Wu W, Li H. (2016). Vaginal delivery of carboplatin-loaded thermosensitive hydrogel to prevent local cervical cancer recurrence in mice. Drug Deliv 23:3544–51.
  • Westphal M, Hilt DC, Bortey E, et al. (2003). A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 5:79–88.
  • Woo BH, Jiang G, Jo YW, Deluca PP. (2001). Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery. Pharm Res 18:1600–6.
  • Yu S, Zhang X, Tan G, et al. (2017). A novel pH-induced thermosensitive hydrogel composed of carboxymethyl chitosan and poloxamer cross-linked by glutaraldehyde for ophthalmic drug delivery. Carbohydr Polym 155:208–17.
  • Zhang G, Wang T, Gao L, Quan D. (2013). Oral delivery of oil-based formulation for a novel synthetic cationic peptide of GnRH (gonadotropin-releasing hormone) antagonist for prostate cancer treatment. Int J Pharm 450:138–44.
  • Zhang J, Wang X, Liu T, et al. (2016). Antitumor activity of electrospun polylactide nanofibers loaded with 5-fluorouracil and oxaliplatin against colorectal cancer. Drug Deliv 23:794–800.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.